Rheumatoid Arthritis Clinical Trial
— WORK-ONOfficial title:
WORK-ON - Vocational Rehabilitation for People With Chronic Inflammatory Arthritis - a Randomised Controlled Trial
People with chronic inflammatory arthritis (IA) (rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis), often have a reduced work ability. Up to 40% lose their job in the first years after diagnosis. Consequently, they are at high risk of losing their jobs and being permanently excluded from the labour market. Therefore, a new context-specific vocational rehabilitation (VR) for people with IA was developed, based on the Medical Research Council's framework for complex interventions. The 6-months VR is called WORK-ON and consists of three parts: 1) a coordinating occupational therapist who performs an initial assessment and goalsetting process and supports cooperation between relevant partners and navigation between sectors, 2) Four group sessions with peers and if needed, 3) Individual sessions with a social worker, nurse, or physiotherapist. The objective of the WORK-ON trial is to test the overall efficacy on work ability compared to a control group who receives usual care and pamphlets for their employer and colleagues. Based on the experiences from a feasibility study, WORK-ON will be conducted as a randomised controlled trial. Patients with IA, aged 18 years or older, experiencing job insecurity will be randomised to one of two groups: the WORK-ON VR group or usual care (control group). The primary outcome; work ability measured is measured by Work Ability Index single item, at baseline, 6, 12, 18 and 30 months after baseline. Secondary outcomes are absenteeism, presenteeism, overall work impairment, activity impairment, job loss, quality of life, mental well-being, fatigue, sleep, physical activity, occupational balance and pain. Secondary outcomes are measured at baseline, 6 and 12 months after baseline. In addition, work ability, working hours per week and job loss are measured at 18 and 30 months after baseline.
Status | Recruiting |
Enrollment | 56 |
Est. completion date | September 1, 2027 |
Est. primary completion date | September 1, 2027 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility | Inclusion Criteria: - =18 years - Diagnosed with RA, PsA or ax-SpA by a rheumatologist. - Undertakes paid work (full or part-time work or studying) - Answers "unlikely" or "not certain" to question #6 from the Work Ability Questionnaire (WAI): "Do you believe, according to your present state of health, that you will be able to do your current job two years from now?" - Willing to participate in a trial of the modified WORK-ON intervention. Exclusion Criteria: - Planned adjustment or change in pharmacological anti-rheumatic treatment. - Morbidities other than IA that may explain reduced work ability. - Under examination for comorbidities influencing their work ability. - Had major surgery within the past six months or if future surgery is planned - Unable to understand or speak Danish at a sufficient level to participate. - Cognitive or psychological impairments that may affect participation. - Involved in another rehabilitation program (apart from physiotherapy). - An ongoing retirement application process or do not plan a retirement within the next three years. - On long-term sick leave (> 4 weeks). |
Country | Name | City | State |
---|---|---|---|
Denmark | Danish Hospital for Rheumatic Diseases | Sønderborg |
Lead Sponsor | Collaborator |
---|---|
The Danish Center for Expertise in Rheumatology | Danish Association of Occupational Therapist, Odense Patient Data Explorative Network, Schaufuss foundation, The Danish Rheumatism Association |
Denmark,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Work Ability Index (WAI) single item | A visual analogue scale that compares perceived work ability with lifetime best score. The score ranges from 0 (completely unable to work) to 10 (work ability at its best) | Baseline to 6 months after baseline | |
Secondary | Job loss | Number of participants who currently has a job | 6,12,18 and 30 months after baseline | |
Secondary | Work hours per week | Number of work hours per week | Baseline, 6,12,18 and 30 months after baseline | |
Secondary | Work Productivity and Activity Impairment questionnaire, general health (WPAI:GH) | Measures Absenteeism, Presenteeism, Overall work impairment and Activity impairment. | Baseline, 6,12,18 and 30 months after baseline | |
Secondary | Sickness absenteeism | Days and hours of sick leave | Each month after baseline during the 6 month intervention period via text message reminders. | |
Secondary | Work ability in relation to demands | Work Ability Index (WAI), question 2 Includes two questions about current work ability in relation to physical and mental demands. | Baseline, 6,12,18 and 30 months after baseline | |
Secondary | Job insecurity | Work ability Index (WAI) question 6 Do you believe, according to your present state of health, that you will be able to do your current job two years from now?" | Baseline, 6,12,18 and 30 months after baseline | |
Secondary | Physical activity while at work | Standing or walking with lifting or carrying Physically demanding job Mostly stationary work Mostly standing or walking | Baseline, 6 and 12 months after baseline | |
Secondary | Occupational balance | Occupational Balance Questionnaire (OBQ-11) that measures measures the participant's experience of balance in the amount and variation of their everyday activities. | Baseline, 6 and 12 months after baseline | |
Secondary | Health related quality of life | EuroQol-5 Dimensions, 5 levels (EQ-5D-5L) is a generic measure to assess population health. Includes five dimensions (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression) -1 to 1, worst to best. | Baseline, 6 and 12 months after baseline | |
Secondary | VAS Pain | Visual analogue scale (VAS) pain, measuring self-rated pain at the moment from 0-10 One question encompassing pain experienced over the previous four weeks and to what extent physical pain affected work and household chores | Baseline, 6 and 12 months after baseline | |
Secondary | Fatigue | Bristol Rheumatoid Arthritis Fatigue Numerical Rating Scales version 2 (BRAF-NRSv2) is three separate numerical rating scales (scored from 0-10, higher is better), which cover three items: fatigue level (severity), effect on life (impact), and coping | Baseline, 6 and 12 months after baseline | |
Secondary | Physical activity | Over the previous year, how would you describe your physical activity? How many days a week are you physically active for at least 30 minutes? | Baseline, 6 and 12 months after baseline | |
Secondary | Mental well-being | WHO-5 Well-being Index, The 5-item Well-Being Index is a generic rating scale measuring subjective well-being. | Baseline, 6 and 12 months after baseline | |
Secondary | Sleep | Number of hours and minutes of sleep during a normal night the previous 4 weeks During the previous 4 weeks, did you get enough sleep to feel rested?
Questions about how you sleep: Did you have trouble falling asleep? Did you wake up several times at night and have difficulty falling asleep? Did you wake up early and were unable to fall asleep again? Did you sleep restlessly? |
Baseline, 6 and 12 months after baseline | |
Secondary | Work Ability Index (WAI) single item | A visual analogue scale that compares perceived work ability with lifetime best score (0-10) The score ranges from 0 (completely unable to work) to 10 (work ability at its best) | 12, 18 and 30 months after baseline |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04226131 -
MusculRA: The Effects of Rheumatoid Arthritis on Skeletal Muscle Biomechanics
|
N/A | |
Completed |
NCT04171414 -
A Study to Evaluate Usability of Subcutaneous Auto-injector of CT-P17 in Patients With Active Rheumatoid Arthritis
|
Phase 3 | |
Completed |
NCT02833350 -
Safety and Efficacy Study of GDC-0853 Compared With Placebo and Adalimumab in Participants With Rheumatoid Arthritis (RA)
|
Phase 2 | |
Completed |
NCT04255134 -
Biologics for Rheumatoid Arthritis Pain (BIORA-PAIN)
|
Phase 4 | |
Recruiting |
NCT05615246 -
Exactech Humeral Reconstruction Prosthesis of Shoulder Arthroplasty PMCF (HRP)
|
||
Completed |
NCT03248518 -
Lessening the Impact of Fatigue in Inflammatory Rheumatic Diseases
|
N/A | |
Completed |
NCT03514355 -
MBSR in Rheumatoid Arthritis Patients With Controlled Disease But Persistent Depressive Symptoms
|
N/A | |
Recruiting |
NCT06005220 -
SBD121, a Synbiotic Medical Food for RA Management
|
N/A | |
Recruiting |
NCT05451615 -
Efficacy and Safety of Abatacept Combined With JAK Inhibitor for Refractory Rheumatoid Arthritis
|
Phase 3 | |
Completed |
NCT05054920 -
Eccentric Versus Concentric Exercises for Rotator Cuff Tendinopathy in Patients With Rheumatoid Arthritis
|
N/A | |
Completed |
NCT02037737 -
Impact and Use of Abatacept IV for Rheumatoid Arthritis in Real Life Setting
|
N/A | |
Recruiting |
NCT04079374 -
Comparative Efficacy, Safety and Immunogenicity Study of Etanercept and Enbrel
|
Phase 3 | |
Completed |
NCT02504268 -
Effects of Abatacept in Patients With Early Rheumatoid Arthritis
|
Phase 3 | |
Recruiting |
NCT05496855 -
Remote Care in People With Rheumatoid Arthritis
|
N/A | |
Completed |
NCT05051943 -
A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response
|
||
Recruiting |
NCT06103773 -
A Study of Single and Multiple Oral Doses of TollB-001
|
Phase 1 | |
Recruiting |
NCT06031415 -
Study of GS-0272 in Participants With Rheumatoid Arthritis
|
Phase 1 | |
Completed |
NCT05999266 -
The Cartilage and Muscle Thickness on Knee Pain in Patients With Rheumatoid Arthritis
|
||
Recruiting |
NCT05302934 -
Evaluation of the PHENO4U Data Platform in Patients Undergoing Total Knee Arthroplasty
|
||
Recruiting |
NCT04169100 -
Novel Form of Acquired Long QT Syndrome
|
Phase 4 |